Individual Investigator Research Awards

These grants are designed to concentrate research in areas that will have the greatest potential to move towards treatments and cures for the inherited orphan retinal degenerative diseases and dry age-related macular degeneration (dAMD).

Current Research Priority Areas are:
- Novel Medical Therapies (NMT)
- Gene Therapy (GT)
- Cell and Molecular Mechanisms of Retinal Disease (CMM)
- Genetics (GE)
- Clinical-Structure and Function (CL)
- Regenerative Medicine (RM)

Funding: $100,000 per year
Duration: 3 years 

Research Authority due date: 6.10.24
​LOI (required) due date: 24.10.24
Full application due date: 6.3.25